Belgium Medical Inc. to Attend the 12th International Conference on Anti-Aging and Biomedical Techn
10/26/2004
Belgium Medical Inc. to Attend the 12th International Conference on Anti-Aging and Biomedical Technologies-October 28-31, 2004, Las Vegas, NevadaVANCOUVER, BRITISH COLUMBIA, Oct 26, 2004 (CCNMatthews via COMTEX) --Meridian Co., Ltd. ("Meridian") (OTC BB: MRDAF), is pleased to announce that its subsidiary, Belgium Medical Inc. ("MMI" or "the Company") will be attending the above referenced conference being held at the Las Vegas Hilton. MMI will be presenting its Digital Pulse Analyzer technology to a variety of medical professionals (MD's, DO's), Scientists, Nutritionists, Chiropractors, RNs/Nurse Practitioners, Naturopathic Doctors and Bariatricians/Weight Management Specialists and virtually any health practitioners interested in integrating anti-aging medicine into their practice. More information on this exciting event can be found at www.worldhealth.net/event. Anti-aging medicine, an extension of preventive health care, is based on the early detection, prevention, and reversal of aging-related disease. Progressive physicians and health care professionals have been using the growing body of research to safely and successfully treat thousands of patients worldwide. There will be more than one thousand physicians and healthcare practitioners seeking innovative treatment modalities for their patients. People are living longer, so by limiting illness and disability in the latter stages of life, anti-aging medicine can make a quantum leap in people's enjoyment of their later years. This is the definitive conference in the field with the most comprehensive display of products, protocols and pharmaceuticals now available. Some exciting statistics in anti-aging medicine as are follows: - The anti-aging marketplace is one that is demographics-driven: people around the world are getting older. As a result the anti-aging marketplace is projected to reach $41.94 billion by 2006, expanding at an average annual rate (AAGR) of 8% (Business Communications Company, 2002) - Prescription Drugs: $70 billion annually spent by the public on medicines prescribed for aging-related diseases - Fifty-Plus Fitness and Spa: $400 billion and growing by 15% each year More About: Digital Pulse Analyzer ("DPA") The "DPA" accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA approved device is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions. The Company feels that use of the "DPA" can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry. Cardiovascular disease is the #1 killer in the United States with an estimated economic cost of approximately $298 billion. More About: Meridian Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of its products. Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity. Website (Korean): www.meridian.co.kr Website (North America): meridianmedical.ca Lexington Communications Larry Kristof 1-877-899-4550 Email: [email protected] NEWS RELEASE TRANSMITTED BY CCNMatthews
|